These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1369621)

  • 1. [Respective role of high doses of immunoglobulins and plasma exchange in the treatment of Guillain-Barré syndrome].
    Raphael JC
    Ann Fr Anesth Reanim; 1992; 11(4):473-4. PubMed ID: 1369621
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous IgG in Guillain-Barré syndrome.
    Hughes RA
    BMJ; 1996 Aug; 313(7054):376-7. PubMed ID: 8761208
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of Guillain-Barré syndrome treated with intravenous high doses of immunoglobulins].
    Mauro G
    Rev Neurol (Paris); 1989; 145(10):731-2. PubMed ID: 2510231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.
    Kleyweg RP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1991 Nov; 54(11):957-60. PubMed ID: 1800666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
    Ng KK; Howard RS; Hirsch NP; Miller DH
    Neurology; 1993 Dec; 43(12):2729; author reply 2730-1. PubMed ID: 8255495
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin versus plasma exchange in Guillain-Barré syndrome.
    van der Meché FG; van Doorn PA; Schmitz PI
    Neurology; 1993 Dec; 43(12):2730; author reply 2730-1. PubMed ID: 8255496
    [No Abstract]   [Full Text] [Related]  

  • 7. [The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G].
    Tagawa Y; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1998; 38(10-11):951-4. PubMed ID: 10203982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.
    van der Meché FG
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):33-4. PubMed ID: 7964849
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome.
    Kleyweg RP; van der Meché FG; Schmitz PI
    Transfus Sci; 1994 Dec; 15(4):389-92. PubMed ID: 10172508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
    Raphaël JC; Annane D; Chevret S; Chillet P; Gajdos P
    Presse Med; 1996 Oct; 25(31):1516-22. PubMed ID: 8958883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
    van der Meché FG
    Ann Med Interne (Paris); 1994; 145(5):293-5. PubMed ID: 7985934
    [No Abstract]   [Full Text] [Related]  

  • 13. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R; Barker J
    N Z Med J; 1998 Nov; 111(1077):433-4. PubMed ID: 9861925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
    Uldry PA; Bogousslavsky J; Regli F
    Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barré syndrome.
    Farcas P; Avnun L; Frisher S; Herishanu YO; Wirguin I
    Lancet; 1997 Dec; 350(9093):1747. PubMed ID: 9413468
    [No Abstract]   [Full Text] [Related]  

  • 17. Minimal number of plasma exchanges needed to reduce immunoglobulin in Guillain-Barré syndrome.
    Yuki N; Tagawa Y; Hirata K
    Neurology; 1998 Sep; 51(3):875-7. PubMed ID: 9748046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous immunoglobulins in Guillain-Barré syndrome].
    Hidou M; Olivier J; Vivant JF
    Ann Fr Anesth Reanim; 1992; 11(1):115. PubMed ID: 1443803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.